Catherine Ramsey
Stock Analyst at Baird
(4.14)
# 488
Out of 5,139 analysts
54
Total ratings
58.54%
Success rate
15.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CSTL Castle Biosciences | Maintains: Outperform | $39 → $41 | $40.01 | +2.47% | 9 | Nov 4, 2025 | |
| ILMN Illumina | Maintains: Neutral | $105 → $109 | $141.65 | -23.05% | 7 | Oct 31, 2025 | |
| RVTY Revvity | Maintains: Outperform | $122 → $123 | $112.50 | +9.33% | 6 | Oct 28, 2025 | |
| WAT Waters | Maintains: Outperform | $374 → $352 | $387.37 | -9.13% | 11 | Jul 16, 2025 | |
| TWST Twist Bioscience | Maintains: Outperform | $54 → $44 | $41.41 | +6.25% | 7 | May 6, 2025 | |
| NTRA Natera | Maintains: Outperform | $183 → $188 | $231.25 | -18.70% | 6 | Feb 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $618.72 | +7.48% | 2 | Nov 1, 2022 | |
| A Agilent Technologies | Maintains: Outperform | $155 → $160 | $139.64 | +14.58% | 5 | Aug 17, 2022 | |
| EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $102.43 | -26.78% | 1 | Aug 3, 2022 |
Castle Biosciences
Nov 4, 2025
Maintains: Outperform
Price Target: $39 → $41
Current: $40.01
Upside: +2.47%
Illumina
Oct 31, 2025
Maintains: Neutral
Price Target: $105 → $109
Current: $141.65
Upside: -23.05%
Revvity
Oct 28, 2025
Maintains: Outperform
Price Target: $122 → $123
Current: $112.50
Upside: +9.33%
Waters
Jul 16, 2025
Maintains: Outperform
Price Target: $374 → $352
Current: $387.37
Upside: -9.13%
Twist Bioscience
May 6, 2025
Maintains: Outperform
Price Target: $54 → $44
Current: $41.41
Upside: +6.25%
Natera
Feb 28, 2025
Maintains: Outperform
Price Target: $183 → $188
Current: $231.25
Upside: -18.70%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $618.72
Upside: +7.48%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $139.64
Upside: +14.58%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $102.43
Upside: -26.78%